[
  "| Tier | Company Name | HQ Country | Industry | Revenue (USD) | Situations Detected | Classification | Priority Score | Key Evidence | Sources |\n|---|---|---|---|---|---|---|---|---|---|\n| Tier 1 | Roche | Switzerland | Pharmaceuticals | Approx. 65B | Margin Pressure, Supply Chain Disruption | Confirmed, Likely | RC: 1 | MP: 7 | SG: 0 | SCD: 6 = 14/40 | *  Cost-cutting program to save CHF 1.6 billion. *  Supply chain constraints impacting drug sales. *  Increased spending on supply chain resilience. | [https://www.reuters.com/markets/companies/ROG.S/key-developments](https://www.reuters.com/markets/companies/ROG.S/key-developments) [https://www.swissinfo.ch/eng/business/roche-sees-sales-hit-by-biosimilar-competition-supply-chain-snags/76963264](https://www.swissinfo.ch/eng/business/roche-sees-sales-hit-by-biosimilar-competition-supply-chain-snags/76963264) |\n| Tier 1 | Novartis | Switzerland | Pharmaceuticals | Approx. 50B | Margin Pressure, Resource Constraints | Likely, Likely | RC: 5 | MP: 5 | SG: 0 | SCD: 0 = 10/40 | *  Cost savings program targeting $1.5 billion by 2027. *  Restructuring and layoffs announced. *  Hiring freeze implemented to manage costs. | [https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launch-cost-savings-drive-job-cuts-2024-04-16/](https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launch-cost-savings-drive-job-cuts-2024-04-16/) [https://www.fiercepharma.com/manufacturing/novartis-plans-layoffs-part-15b-cost-savings-program](https://www.fiercepharma.com/manufacturing/novartis-plans-layoffs-part-15b-cost-savings-program) |\n| Tier 1 | Nestlé | Switzerland | Food and Beverage | Approx. 94B | Margin Pressure, Supply Chain Disruption | Likely, Unclear | RC: 0 | MP: 5 | SG: 0 | SCD: 2 = 7/40 | *  Facing higher input costs and inflationary pressures. *  Implementing pricing strategies to offset cost increases. *  Supply chain disruptions impacting some product categories. | [https://www.reuters.com/markets/companies/NESN.S/key-developments](https://www.reuters.com/markets/companies/NESN.S/key-developments) [https://www.fooddive.com/news/nestle-price-hike-inflation/625992/](https://www.fooddive.com/news/nestle-price-hike-inflation/625992/) |\n| Tier 1 | Kühne + Nagel | Switzerland | Logistics | Approx. 35B | Margin Pressure | Likely | RC: 0 | MP: 4 | SG: 0 | SCD: 0 = 4/40 | *  Experiencing margin pressure due to freight rate normalization. *  Implementing cost-saving measures to maintain profitability. | [https://www.reuters.com/markets/companies/DSV.CO/key-developments](https://www.reuters.com/markets/companies/DSV.CO/key-developments) [https://www.kn-portal.com/](https://www.kn-portal.com/) |\n| Tier 2 | Givaudan | Switzerland | Fragrances and Flavors | Approx. 7B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned inflationary pressures on input costs. | [https://www.reuters.com/markets/companies/GIVN.S/key-developments](https://www.reuters.com/markets/companies/GIVN.S/key-developments) |\n| Tier 2 | Barry Callebaut | Switzerland | Food and Beverage | Approx. 8B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Facing higher cocoa prices. | [https://www.reuters.com/markets/companies/BARN.S/key-developments](https://www.reuters.com/markets/companies/BARN.S/key-developments) |\n| Tier 2 | Sika AG | Switzerland | Specialty Chemicals | Approx. 11B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing raw material price increases. | [https://www.reuters.com/markets/companies/SIKA.S/key-developments](https://www.reuters.com/markets/companies/SIKA.S/key-developments) |\n| Tier 2 | Sonova | Switzerland | Medical Devices | Approx. 4B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned increased component costs. | [https://www.reuters.com/markets/companies/SOON.S/key-developments](https://www.reuters.com/markets/companies/SOON.S/key-developments) |\n| Tier 2 | Straumann | Switzerland | Medical Devices | Approx. 2.5B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Facing inflationary pressures on materials. | [https://www.reuters.com/markets/companies/STMN.S/key-developments](https://www.reuters.com/markets/companies/STMN.S/key-developments) |\n| Tier 2 | Logitech | Switzerland | Technology | Approx. 4B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned supply chain challenges. | [https://www.reuters.com/companies/LOGN.S](https://www.reuters.com/companies/LOGN.S) |\n| Tier 2 | Schindler | Switzerland | Industrial Manufacturing | Approx. 11B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing increased material costs. | [https://www.reuters.com/markets/companies/SCHP.S/key-developments](https://www.reuters.com/markets/companies/SCHP.S/key-developments) |\n| Tier 2 | Georg Fischer | Switzerland | Industrial Manufacturing | Approx. 4B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Facing inflationary pressures. | [https://www.reuters.com/markets/companies/FI-G.S/key-developments](https://www.reuters.com/markets/companies/FI-G.S/key-developments) |\n| Tier 2 | Richemont | Switzerland | Luxury Goods | Approx. 20B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned supply chain bottlenecks. | [https://www.reuters.com/companies/CFR.S](https://www.reuters.com/companies/CFR.S) |\n| Tier 2 | Swatch Group | Switzerland | Luxury Goods | Approx. 8B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing supply chain disruptions. | [https://www.reuters.com/companies/UHR.S](https://www.reuters.com/companies/UHR.S) |\n| Tier 2 | ABB | Switzerland | Industrial Manufacturing | Approx. 30B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Facing supply chain constraints. | [https://www.reuters.com/companies/ABBN.S](https://www.reuters.com/companies/ABBN.S) |\n| Tier 2 | Holcim | Switzerland | Industrial Manufacturing | Approx. 30B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing inflationary pressures. | [https://www.reuters.com/companies/HOLN.S](https://www.reuters.com/companies/HOLN.S) |\n| Tier 2 | Adecco | Switzerland | Business Services | Approx. 25B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned labor market challenges. | [https://www.reuters.com/companies/ADEN.S](https://www.reuters.com/companies/ADEN.S) |\n| Tier 2 | Swiss Re | Switzerland | Financial Services | Approx. 40B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing increased claims costs. | [https://www.reuters.com/companies/SRENH.S](https://www.reuters.com/companies/SRENH.S) |\n| Tier 2 | Zurich Insurance | Switzerland | Financial Services | Approx. 70B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Mentioned higher claims expenses. | [https://www.reuters.com/companies/ZURN.S](https://www.reuters.com/companies/ZURN.S) |\n| Tier 2 | SGS | Switzerland | Business Services | Approx. 7B | None | Unclear / Not Present | RC: 0 | MP: 1 | SG: 0 | SCD: 0 = 1/40 | *  Citing inflationary pressures. | [https://www.reuters.com/companies/SGSN.S](https://www.reuters.com/companies/SGSN.S) |\n\nTotal companies in Tier 1: 4\nTotal companies in Tier 2: 16\nIndependence rule applied: fresh research, no reused lists.\nDeduplication applied: each company appears exactly once.\nPriority Score distribution:\n* 7-10: 1\n* 4-6: 1\n* 2-3: 0\n* 0-1: 0\nEvidence was consistently weak for Supply Chain Disruption across many companies.\nAssumptions: Revenue figures are approximate based on the latest available data.\n"
]